Experimental and bioinformatics studies have also demonstrated that the level of SLC3A2 protein is significantly elevated in bladder cancer tumor cells compared to non-cancerous bladder epithelial cells, suggesting that SLC3A2 may serve as a useful tumor tissue marker for the diagnosis of bladder cancer patients (53–55). This evidence concerns the gene SLC3A2 and neoplasm.